• This email address is being protected from spambots. You need JavaScript enabled to view it.
Aurum at the 53rd Union World Conference on Lung Health

Aurum at the 53rd Union World Conference on Lung Health

The Aurum Institute will join colleagues, partners, advocates and friends at the biggest scientific conference on lung health, The Union World Conference on Lung Health which will take place virtually from 8-11 November 2022.
Our technical experts will share findings from various projects on digital adherence technologies, clinical research on TB vaccines and new treatments, TB preventive treatment and TB and COVID-19. 

Some of these experts, will be on hand to engage with conference attendees at our virtual exhibition stand. We will also share information about all our current TB projects, which will be available for download. If you are attending the conference, please also look out for the Union Conference video series which will include Prof Violet Chihota, Chief Specialist Scientist, speaking about how innovations from the COVID-19 pandemic can be used in TB recovery programmes.
You can follow us on social media before, during and after the conference to learn all about what Aurum is doing to advance health science and innovation in TB, COVID and HIV.

Aurum looks forward to sharing the work we do to create a TB-free world for future generations.


Wednesday, 9 November 2022

Plenary Session
Time: 14:00 - 15:00
Co-chair: Dr Matsie Mphahlele, Senior Technical Advisor
It’s time to rethink respiratory disease transmission and how to prevent it. 

TB Science Session
Time: 17:25 - 18:15
Co-chair: Prof Gavin Churchyard, Group Chief Executive Officer
Where are we in addressing post-TB lung disease?


SP-07 Scale up of short course preventive treatment for TB- Evidence to Policy, Policy to Practice
Presenter: Makaita Gombe, Senior Programme Manager
Tuesday, 8 November 2022. 16:30 – 17:50. Channel 2
Symposium: Large-scale implementation of short-course TB preventive treatment regimens: experiences from the field. 

SP-12 The use of digital adherence technologies to improve TB treatment outcomes: results from the TB MATE study in South Africa
Presenter: Prof Salome Charalambous, Group Chief Scientific Officer
Wednesday, 9 November 2022. 12:30 – 13:50. Channel 3
Symposium: Digital health technologies for providing person-centred tuberculosis care: country experiences and suggested strategies for scale-up. 

SP-28 Implications of the Full Value Assessment of Novel TB Vaccines for South African country level decision making
Presenter: Prof Salome Charalambous
Thursday, 10 November 2022. 16:30 - 17:50. Channel 2
Symposium: Full value assessment of novel TB vaccines: combating pandemics today and tomorrow.

SP-36 TB vaccine efficacy trials: update and implications for scale up
Presenter: Prof Gavin Churchyard
Friday, 11 November 2022. 16:30 - 17:50. Channel 1
Symposium: Laying the groundwork for the success of new TB vaccines TB vaccine efficacy trials: update and implications for scale up.


Tuesday, 08 November

OA-10 Clinical trials and operational research for new treatment for TB (adults and children)
Time: 16:30 - 17:50. Channel 3
Speaker: Prof Salome Charalambous
Topic: Monitoring for hepatoxicity among HIV-positive patients on ART and isoniazid and rifapentine for treatment of TB infection.

Wednesday, 09 November 

OA-11 Expanding active case finding in vulnerable populations
Time: 11:00 - 12:20. Channel 2
Speaker: Tanyaradzwa Dube, Junior Research Manager
Topic: Facilitating and inhibiting factors for the introduction of digital adherence tools for TB care: analysis of multi-country, cluster randomised trial data.

OA-18 Identification and Management of TB Infection
Time: 16:30 - 17:50. Channel 3
Speaker: Prof Violet Chihota, Chief Specialist Scientist 
Topic: Short-course rifapentine and isoniazid preventive treatment among PLHIV in low and middle-income countries is safe and associated with high treatment completion rates.

OA-16 Implementation of TPT
Time: 16:30 – 17:50. Channel 2
Speaker: Dr Lindiwe Tsope, Project Coordinator
Topic: Scale-up of short-course TB preventive treatment (3HP) in high TB burden countries: The IMPAACT4TB Project.

Thursday, 10 November

OA-24 Person-centred care: how new technologies can support – TB Science
Time: 16:30 – 17:50. Channel 1
Speaker: Rachel Mukora, Health Economist
Topic: Patient acceptability of using medication monitors and experience of a differentiated care approach for TB treatment adherence in South Africa.


EP-10-693 Provider costs of using medication monitors and a differentiated care approach to improve TB treatment adherence in South Africa. Rachel Mukora.

EP-11-705 Resistance to M. tuberculosis infection among highly TB exposed, HIV-infected goldminers in South Africa - Thobani Ntshiqa, Senior Research Manager.

EP-27-870 TB treatment adherence among drug-susceptible TB persons using a medication monitor and differentiated care vs. standard of care in South Africa. Dr Noriah Maraba, Scientist.

EP-41-1015  Post-hospitalisation lung function outcomes in patients with symptomatic COVID-19 disease from a tertiary facility, South Africa. Dr Nicole Glover, Medical Officer.

EP-41-1017 Implementation of bi-directional screening of COVID-19 and TB in community posts in Mozambique. Oral Presenter: Elzier Mangunyane, Programme Manager: Fundação Aurum.

© 2024 The Aurum Institute. All Rights Reserved.